Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 Sep 15;294(Pt 3):681–684. doi: 10.1042/bj2940681

Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme.

C H Williams 1, T Yamamoto 1, D M Walsh 1, D Allsop 1
PMCID: PMC1134516  PMID: 8379924

Abstract

It was reported recently that N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide (CPP-A-A-F-pAB), an inhibitor of endopeptidase 3.4.24.15 (E-24.15), also inhibits angiotensin-converting enzyme (ACE) from rabbit lung. We have found that this compound is without effect on ACE purified from pig kidney, at a concentration some 1000-fold greater than the Ki reported for inhibition of the enzyme from lung. However, preincubation of CPP-A-A-F-pAB with neutral endopeptidase 3.4.24.11 (E-24.11) does result in potent inhibitory effects on ACE. We have shown this to be due to formation of a fragment, CPP-A-A, the structure of which is closely related to ACE inhibitors such as enalaprilat. CPP-A-A was found to be a potent inhibitor of pig ACE. Under the conditions used it had an IC50 value of 1.6 x 10(-8) M, compared with the value obtained for captopril of 7.5 x 10(-10) M. These results have important implications for studies of E-24.15 when using CPP-A-A-F-pAB in vivo or in crude tissue extracts where E-24.11 might also be present.

Full text

PDF
681

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acker G. R., Molineaux C., Orlowski M. Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8. J Neurochem. 1987 Jan;48(1):284–292. doi: 10.1111/j.1471-4159.1987.tb13160.x. [DOI] [PubMed] [Google Scholar]
  2. Barelli H., Vincent J. P., Checler F. Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum. Eur J Biochem. 1988 Aug 15;175(3):481–489. doi: 10.1111/j.1432-1033.1988.tb14220.x. [DOI] [PubMed] [Google Scholar]
  3. Chappell M. C., Welches W. R., Brosnihan K. B., Ferrario C. M. Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate. Peptides. 1992 Sep-Oct;13(5):943–946. doi: 10.1016/0196-9781(92)90053-6. [DOI] [PubMed] [Google Scholar]
  4. Checler F., Vincent J. P., Kitabgi P. Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase. J Neurochem. 1985 Nov;45(5):1509–1513. doi: 10.1111/j.1471-4159.1985.tb07220.x. [DOI] [PubMed] [Google Scholar]
  5. Checler F., Vincent J. P., Kitabgi P. Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes. J Biol Chem. 1986 Aug 25;261(24):11274–11281. [PubMed] [Google Scholar]
  6. Genden E. M., Molineaux C. J. Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats. Hypertension. 1991 Sep;18(3):360–365. doi: 10.1161/01.hyp.18.3.360. [DOI] [PubMed] [Google Scholar]
  7. Holmquist B., Bünning P., Riordan J. F. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem. 1979 Jun;95(2):540–548. doi: 10.1016/0003-2697(79)90769-3. [DOI] [PubMed] [Google Scholar]
  8. Millican P. E., Kenny A. J., Turner A. J. Purification and properties of a neurotensin-degrading endopeptidase from pig brain. Biochem J. 1991 Jun 15;276(Pt 3):583–591. doi: 10.1042/bj2760583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mumford R. A., Pierzchala P. A., Strauss A. W., Zimmerman M. Purification of a membrane-bound metalloendopeptidase from porcine kidney that degrades peptide hormones. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6623–6627. doi: 10.1073/pnas.78.11.6623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Orlowski M., Michaud C., Chu T. G. A soluble metalloendopeptidase from rat brain. Purification of the enzyme and determination of specificity with synthetic and natural peptides. Eur J Biochem. 1983 Sep 1;135(1):81–88. doi: 10.1111/j.1432-1033.1983.tb07620.x. [DOI] [PubMed] [Google Scholar]
  11. Orlowski M., Michaud C., Molineaux C. J. Substrate-related potent inhibitors of brain metalloendopeptidase. Biochemistry. 1988 Jan 26;27(2):597–602. doi: 10.1021/bi00402a015. [DOI] [PubMed] [Google Scholar]
  12. Orlowski M., Reznik S., Ayala J., Pierotti A. R. Endopeptidase 24.15 from rat testes. Isolation of the enzyme and its specificity toward synthetic and natural peptides, including enkephalin-containing peptides. Biochem J. 1989 Aug 1;261(3):951–958. doi: 10.1042/bj2610951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Patchett A. A., Cordes E. H. The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme. Adv Enzymol Relat Areas Mol Biol. 1985;57:1–84. doi: 10.1002/9780470123034.ch1. [DOI] [PubMed] [Google Scholar]
  14. Patchett A. A., Harris E., Tristram E. W., Wyvratt M. J., Wu M. T., Taub D., Peterson E. R., Ikeler T. J., ten Broeke J., Payne L. G. A new class of angiotensin-converting enzyme inhibitors. Nature. 1980 Nov 20;288(5788):280–283. doi: 10.1038/288280a0. [DOI] [PubMed] [Google Scholar]
  15. Pierotti A., Dong K. W., Glucksman M. J., Orlowski M., Roberts J. L. Molecular cloning and primary structure of rat testes metalloendopeptidase EC 3.4.24.15. Biochemistry. 1990 Nov 13;29(45):10323–10329. doi: 10.1021/bi00497a006. [DOI] [PubMed] [Google Scholar]
  16. Tisljar U., Barrett A. J. Thiol-dependent metallo-endopeptidase characteristics of Pz-peptidase in rat and rabbit. Biochem J. 1990 Apr 15;267(2):531–533. doi: 10.1042/bj2670531. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES